Skip to main content


Grade III anaphylaxis: case report

This is a preview of subscription content, access via your institution.


  • Puebla Villaescusa A, et al. Effectiveness of omalizumab and bee venom immunotherapy combination: Case report. European Journal of Hospital Pharmacy - Science and Practice 27 (Suppl.): A207, Mar 2020. Available from: URL: [abstract]

Download references

Rights and permissions

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bee-venom-allergy-immunotherapy. Reactions Weekly 1829, 99 (2020).

Download citation

  • Published:

  • Issue Date:

  • DOI: